Panel discussion
*Vladimir Dragalin, Aptiv Solutions  *Paul Gallo, Novartis  *Brenda Gaydos, Eli Lilly and Company  *James Hung, FDA  *LJ Wei, Harvard School of Public Health 

Keywords: Adaptive designs

Panelists: James Hung, FDA; Paul Gallo, Novartis; Vladimir Dragalin, Aptiv Solutions; Brenda Gaydos, Eli Lilly and Company; LJ Wei, Harvard School of Public Health